To be excited, there existing be an significant intersection between miRNAs-target pathways and NEURL1B-target pathways, suggesting that miR-17 and miR-27a might promote tumor cell malignant property by targeting NEURL1B via the activation of PI3K/AKT signaling pathway. This evidence concerns the gene NEURL1B and neoplasm.